U
Adaptogenics Health Corp. ADPT
CNSX
Recommendation
Prev Close
$0.035
Volume
--
Avg Vol (90D)
2,853
Market Cap
$415.48K
Dividend & Yield
--
52-Week Range
$0.02 - $0.065
P/E (TTM)
--
EPS (TTM)
--
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Adaptive Biotechnologies (ADPT, $6.83) Stochastic Oscillator left the oversold zone on April 21, 2025
4/22/2025 - Tickeron - Stocks
Franklin Resources Inc. Invests $443,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
4/20/2025 - MarketBeat
Adaptive Biotechnologies (ADPT, $7.49) entered Downtrend as Momentum indicator drops below 0 level on Apr 16, 2025
4/17/2025 - Tickeron - Stocks
Adaptive Biotechnologies (ADPT, $7.49) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 16, 2025
4/17/2025 - Tickeron - Stocks
Adaptive Biotechnologies (ADPT, $7.82) price exceeded its 50-day Moving Average on April 14, 2025
4/15/2025 - Tickeron - Technical Analysis
Adaptive Biotechnologies (ADPT, $7.94) entered Uptrend as Momentum indicator ascends above 0 level on Apr 11, 2025
4/12/2025 - Tickeron - Stocks
Adaptive Biotechnologies (ADPT, $7.94) price moved above its 50-day Moving Average on April 11, 2025
4/12/2025 - Tickeron - Stocks
ExodusPoint Capital Management LP Takes $1.48 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
4/12/2025 - MarketBeat
Adaptive Biotechnologies (ADPT, $7.73) price exceeded its 50-day Moving Average on April 10, 2025
4/11/2025 - Tickeron - Technical Analysis
Adaptive Biotechnologies (ADPT, $7.73) entered Downtrend as Momentum indicator drops below 0 level on Apr 10, 2025
4/11/2025 - Tickeron - Technical Analysis
Adaptive Biotechnologies Corp (ADPT) Announces Upcoming Q1 2025 Financial Results Release ...
4/10/2025 - GuruFocus
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
4/10/2025 - GuruFocus
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 ADPT ...
4/10/2025 - GuruFocus
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
4/10/2025 - Globe Newswire
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 9.4% - Here's What Happened
4/10/2025 - MarketBeat
Why Investors Shouldn't Be Surprised By Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) 26% Share Price Surge
4/10/2025 - Simply Wall St
Adaptive Biotechnologies (ADPT, $8.38) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 9, 2025
4/10/2025 - Tickeron - Stocks
Adaptive Biotechnologies (ADPT, $8.38) entered Uptrend as Momentum indicator ascends above 0 level on Apr 09, 2025
4/10/2025 - Tickeron - Stocks
Adaptive Biotechnologies (ADPT, $8.38) price moved above its 50-day Moving Average on April 09, 2025
4/10/2025 - Tickeron - Stocks
Adaptive Biotechnologies Corp (ADPT) Expands clonoSEQ Coverage for Mantle Cell Lymphoma Patients
4/8/2025 - GuruFocus
Adaptive Biotechnologies receives expanded medical coverage of clonoSEQ
4/8/2025 - The Fly
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ for Surveillance in Mantle Cell Lymphoma
4/8/2025 - Globe Newswire
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Stock Holdings Lifted by Massachusetts Financial Services Co. MA
4/7/2025 - Ticker Report
Cinctive Capital Management LP Buys Shares of 241,316 Adaptive Biotechnologies Co. (NASDAQ:ADPT)
4/6/2025 - MarketBeat
Adaptive Biotechnologies (ADPT, $7.41) entered Downtrend as Momentum indicator drops below 0 level on Apr 03, 2025
4/4/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
--
Total Liabilities (Q)
--
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Period Date
Next Filing
(est)
Price History
Loading...
Beta
-2.21
7-Day Total Return
-14.29%
30-Day Total Return
20.00%
60-Day Total Return
0.00%
90-Day Total Return
-45.45%
Year to Date Total Return
-40.00%
1-Year Total Return
-14.29%
2-Year Total Return
-57.14%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
May 28, 2024 - $0.02
52-week High
Dec 09, 2024 - $0.065
Valuation
Market Cap
$415.48K - Nano Cap
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
--
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
adaptogenicshealth.com
Phone Number
888 317 9998
Address
1111 Melville Street
Vancouver, BC V6E 3V6
Country
Canada
Year Founded
2021
Business Description
Sector
Consumer Staples
Industry
Household and Personal Products
Adaptogenics Health Corp., a nutraceutical company, focuses on the formulation and distribution of functional mushroom products and nutritional supplement alternatives in Canada. The company was... more